ACET - Adicet Bio

-

$undefined

N/A

(N/A)

Adicet Bio NASDAQ:ACET Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

Location: 500 Boylston St Fl 12, Massachusetts, 02116-3740, US | Website: www.adicetbio.com | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-89.58M

Cash

224.1M

Avg Qtr Burn

-22.75M

Short % of Float

5.99%

Insider Ownership

1.59%

Institutional Own.

76.37%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.